Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study

Emilien Jeannot, Manuella Viviano, Charlotte De Pree, Mona Amadane, Emmanuel Kabengele, Pierre Vassilakos and Patrick Petignat
Additional contact information
Emilien Jeannot: Institute of Global Health-Faculty of Medicine, Chemin de Mines 9, 1202 Geneva, Switzerland
Manuella Viviano: Gynecology Division, Department of Obstetrics and Gynecology, Geneva University Hospitals, Boulevard de la Cluse 30, 1205 Geneva, Switzerland
Charlotte De Pree: Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
Mona Amadane: Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
Emmanuel Kabengele: Institute of Global Health-Faculty of Medicine, Chemin de Mines 9, 1202 Geneva, Switzerland
Pierre Vassilakos: Geneva Foundation for Medical Education and Research, Route de Ferney 150, 1211 Geneva 2, Switzerland
Patrick Petignat: Gynecology Division, Department of Obstetrics and Gynecology, Geneva University Hospitals, Boulevard de la Cluse 30, 1205 Geneva, Switzerland

IJERPH, 2018, vol. 15, issue 7, 1-11

Abstract: Background: The human papillomavirus (HPV) vaccination program for young girls aged 11–26 years was introduced in Switzerland in 2008. The objective of this study was to evaluate the prevalence of high- and low-risk HPV in a population of undergraduate students using self-sampling for monitoring the HPV vaccination program’s effect. Methods: Undergraduate women aged between 18–31 years, attending the Medical School and University of Applied Sciences in Geneva, were invited to participate in the study. Included women were asked to perform vaginal self-sampling for HPV testing using a dry cotton swab. Results: A total of 409 students participated in the study—aged 18–31 years—of which 69% of the participants were vaccinated with Gardasil HPV vaccine and 31% did not received the vaccine. About HPV prevalence, 7.2% of unvaccinated women were HPV 16 or 18 positive, while 1.1% of vaccinated women were infected by HPV 16 or 18 ( p < 0.01). Prevalence of HPV 6 and 11 was 8.3% in non-vaccinated women versus 2.1% in vaccinated women ( p < 0.02). We observed no cross-protection for the other HPV genotypes of a low- and high-risk strain. Conclusions: Prevalence of HPV 6/11/16/18 was lower in vaccinated women versus unvaccinated women. Continued assessment of HPV vaccine effectiveness in real population is needed.

Keywords: HPV; self-sampling; vaccination (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/1660-4601/15/7/1447/pdf (application/pdf)
https://www.mdpi.com/1660-4601/15/7/1447/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:15:y:2018:i:7:p:1447-:d:157041

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().